Skip to main content
Log in

Advanced hybrid closed-loop Mini-Med 780G system cost effective for T1DM in Sweden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Medtronic.

  2. 2019 Swedish krona

Reference

  • Jendle J, et al. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden. Diabetes Therapy : 12 Nov 2021. Available from: URL: https://doi.org/10.1007/s13300-021-01157-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Advanced hybrid closed-loop Mini-Med 780G system cost effective for T1DM in Sweden. PharmacoEcon Outcomes News 892, 1 (2021). https://doi.org/10.1007/s40274-021-08196-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08196-6

Navigation